Terms: = Cervical cancer AND AFP, AFPD, FETA, HPAFP
43 results:
1. MLK4 as an immune marker and its correlation with immune infiltration in cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract] [Full Text] [Related]
2. Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2021.
Teutsch SM; Nunez CA; Morris A; Eslick GD; Berkhout A; Novakovic D; Brotherton JM; McGregor S; Khawar L; Khandaker G; Booy R; Jones CA; Rawlinson W; Thorley BR; Elliott EJ
Commun Dis Intell (2018); 2022 Oct; 46():. PubMed ID: 36303401
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced cervical cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Jiang Y; Song B; Chen Z
Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2.
Wei W; Huang X; Shen X; Lian J; Chen Y; Wang W; Huang J; Zhang B
Crit Rev Eukaryot Gene Expr; 2022; 32(1):1-9. PubMed ID: 35377976
[TBL] [Abstract] [Full Text] [Related]
5. Gynecologic cancer in pregnancy.
Korenaga TK; Tewari KS
Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract] [Full Text] [Related]
7. Serum afp levels in patients suffering from 47 different types of cancers and noncancer diseases.
He Y; Lu H; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():199-212. PubMed ID: 30905450
[TBL] [Abstract] [Full Text] [Related]
8. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and afp in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract] [Full Text] [Related]
9. Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Gushima R; Narita R; Shono T; Naoe H; Yao T; Sasaki Y
J Gastrointestin Liver Dis; 2017 Jun; 26(2):193-197. PubMed ID: 28617891
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative prediction of poor prognostic parameters and adjuvant treatment in women with pure endometrioid type endometrial cancer: what is the significance of tumor markers?
Baser E; Gungor T; Togrul C; Turkoglu O; Celen S
Eur J Gynaecol Oncol; 2014; 35(5):513-8. PubMed ID: 25423695
[TBL] [Abstract] [Full Text] [Related]
11. [A case of primary unknown cancer difficult to distinguish from lung cancer].
Tanaka Y; Tago K; Narabayashi T; Sasaki Y; Iwahashi E; Hibino C; Iwasaki T; Watanabe T; Kasugai T; Kohama J; Ohno K
Gan To Kagaku Ryoho; 2014 May; 41(5):627-31. PubMed ID: 24917010
[TBL] [Abstract] [Full Text] [Related]
12. Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.
Li Y; Chen Z; Li F; Wang J; Zhang Z
Int J Nanomedicine; 2012; 7():4593-611. PubMed ID: 22956868
[TBL] [Abstract] [Full Text] [Related]
13. Combined analysis of afp and HCCR-1 as an useful serological marker for small hepatocellular carcinoma: a prospective cohort study.
Zhang G; Ha SA; Kim HK; Yoo J; Kim S; Lee YS; Hur SY; Kim YW; Kim TE; Park YG; Wang J; Yang Y; Xu Z; Song EY; Huang Z; Jirun P; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Kim JW
Dis Markers; 2012; 32(4):265-71. PubMed ID: 22430193
[TBL] [Abstract] [Full Text] [Related]
14. Simultaneous measurements of serum afp, GPC-3 and HCCR for diagnosing hepatocellular carcinoma.
Qiao SS; Cui ZQ; Gong L; Han H; Chen PC; Guo LM; Yu X; Wei YH; Ha SA; Kim JW; Jin ZT; Li S; Peng JR; Leng XS
Hepatogastroenterology; 2011; 58(110-111):1718-24. PubMed ID: 21940340
[TBL] [Abstract] [Full Text] [Related]
15. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract] [Full Text] [Related]
16. [An autopsy case of alpha-fetoprotein-producing carcinoma of the sigmoid colon resulting in sudden death].
Asakage N; Haraguchi Y; Suzuki T; Kobayashi S; Yamasaki S
Nihon Shokakibyo Gakkai Zasshi; 2010 Aug; 107(8):1296-304. PubMed ID: 20693754
[TBL] [Abstract] [Full Text] [Related]
17. Serum tumour markers in gynaecological cancers.
Aggarwal P; Kehoe S
Maturitas; 2010 Sep; 67(1):46-53. PubMed ID: 20510555
[TBL] [Abstract] [Full Text] [Related]
18. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.
Sturgeon CM; Duffy MJ; Hofmann BR; Lamerz R; Fritsche HA; Gaarenstroom K; Bonfrer J; Ecke TH; Grossman HB; Hayes P; Hoffmann RT; Lerner SP; Löhe F; Louhimo J; Sawczuk I; Taketa K; Diamandis EP;
Clin Chem; 2010 Jun; 56(6):e1-48. PubMed ID: 20207771
[TBL] [Abstract] [Full Text] [Related]
19. Clear cell adenocarcinoma of the uterine cervix in a young pregnant woman: a case report with immunohistochemical study.
Terada T
Med Oncol; 2011 Mar; 28(1):290-3. PubMed ID: 20054717
[TBL] [Abstract] [Full Text] [Related]
20. [Reversal of multidrug resistance in hepatocellular cell line HepG2R by mdr1-antisense RNA].
Mei Y; Shi YJ; Ding X; Jian HG; Gong JP; Liu CA; Chen XG
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):594-8. PubMed ID: 19719917
[TBL] [Abstract] [Full Text] [Related]
[Next]
